Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 8;64(37):e202508192.
doi: 10.1002/anie.202508192. Epub 2025 Aug 4.

Bioelectrosynthesis of Signaling Molecules for Selective Modulation of Cell Signaling

Affiliations

Bioelectrosynthesis of Signaling Molecules for Selective Modulation of Cell Signaling

Myeongeun Lee et al. Angew Chem Int Ed Engl. .

Abstract

Bioelectrosynthesis holds great potential for studying and regulating biological systems through the in situ synthesis and delivery of cell signaling molecules with high spatiotemporal precision. Despite recent advancements, precise control over multiple signaling molecules within a single platform remains challenging. Here, we introduce a bioelectrosynthesis approach capable of selectively producing two types of signaling molecules from a single precursor. This system leverages multi-metal sulfide electrocatalysts inspired by denitrifying enzymes, which generate signaling molecules, nitric oxide (NO), and ammonia (NH3) from nitrite ions. By controlling catalytic active sites, NO or NH3 can be selectively produced under mild electric fields in physiologically relevant conditions. In situ product analyses and first-principles calculations reveal that NO intermediate binding affinity determines product selectivity. These electrocatalysts integrate seamlessly with biological systems, allowing precise, on-demand modulation of NO- or NH3-mediated signaling pathways in human cell lines. By combining electrochemical precision with selective cell control, this strategy may advance the study and regulation of biological systems.

Keywords: Biocatalysis; Bioelectrosynthesis; Computational chemistry; Electrochemistry; Signal transduction.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
A schematic of a bioelectrosynthesis approach for the independent and selective production of signaling molecules from the NO2 ion. The control of active sites in the electrocatalysts determines the selectivity toward NO and NH3, offering an independent modulation of corresponding cell signaling.
Figure 2
Figure 2
a) Schematic representation of the crystal structure of Cu2MoS4. Mo, Cu, and S atoms are marked in purple, orange, and yellow, respectively. b) XRD patterns for synthesized Cu2MoS4 and FeCuMoS4. c) HRTEM, d) STEM, and e) STEM‐EDS mapping images of synthesized Cu2MoS4. f) A schematic of the Fe doping process for Cu2MoS4 to synthesize FeCuMoS4. Doped Fe ions are depicted in dotted circles. g) ICP‐OES results of Cu2MoS4 and FeCuMoS4 indicated that doped Fe ions preferentially substituted the Cu ions. h) HRTEM, i) STEM, and j) STEM‐EDS mapping images of FeCuMoS4. The STEM‐EDS mapping image indicated uniform distributions of Cu (red), Mo (blue), and Fe (green) ions inside the crystal.
Figure 3
Figure 3
CV curves of the a) bare carbon, b) Cu2MoS4‐loaded, and c) FeCuMoS4‐loaded electrodes in the presence or absence of 0.1 M NO2 containing Tyrode's solution at a scan rate of 50 mV s−1. Chronoamperometry profiles of d) Cu2MoS4‐loaded and e) FeCuMoS4‐loaded electrodes at the applied voltage from −1.0 to −2.0 V versus Ag/AgCl. FENH4+ (mean ± SD) with the f) Cu2MoS4 or h) FeCuMoS4 electrocatalysts and FENO (mean ± SD) with the g) Cu2MoS4 or i) FeCuMoS4 electrocatalysts at various applied voltage conditions, respectively (n = 3 independent experiments per group). A potential range from −1.0 to −2.0 V versus Ag/AgCl was utilized for the analysis.
Figure 4
Figure 4
Configurations illustrating the binding of NO2 to a) Cu2MoS4 and b) FeCuMoS4 surfaces. Cu, Mo, Fe, S, N, and O atoms were marked in orange, purple, cyan, yellow, blue, and red circles, respectively. c) Gibbs free energy diagrams for the NO2 reduction reaction catalyzed by Cu2MoS4 at an applied potential (U) of 0 V (black) and 0.38 V versus the RHE (blue). d) Gibbs free energy diagrams for the NO2 reduction reaction catalyzed by FeCuMoS4 at U = 0 V (black) and 0.77 V versus RHE (blue). Atomic Bader charge analyses for e) Cu in Cu2MoS4 and f) Fe in FeCuMoS4 before (gray) and after (black) binding to NO. g) Changes in Bader charge of NO after the binding to Cu2MoS4 and FeCuMoS4. h) A schematic illustrating the strong back‐pi bonding between the Fe active site and NO intermediates in FeCuMoS4.
Figure 5
Figure 5
TRPV1 activation with electrochemically produced NO. a) Schematic representation of two plasmids used to generate genetically engineered cells co‐expressing TRPV1 and GCaMP6s (left) and the mechanism of NO‐mediated activation of TRPV1 and subsequent Ca2+ influx (right). b) Schematic illustrating selective activation of TRPV1 by electrochemically produced NO, but not by NH3. Here, cells were positioned near the electrode where localized electrosynthesis of NO or NH3 occurred. Individual GCaMP6s fluorescence traces for 150 TRPV1+ cells upon application of a voltage of −1.2 V versus Ag/AgCl to c) Cu2MoS4 and d) FeCuMoS4 electrocatalysts. The voltages were turned on at 30 s (dashed lines), and continuous electrochemical synthesis was performed until 900 s. Here, HEK ID represents individual cells analyzed, and each horizontal line displays the GCaMP6s fluorescence changes of the individual cell over time. A total of 150 cells were analyzed for each condition (n = 3 independent experiments per group). e) Schematic depiction of time‐lapse imaging showing sequential activation of TRPV1+ cells during electrosynthesis of NO. Time points t1, t2, and t3 represent increasing durations of electrolysis, with TRPV1+ cells located farther from the electrode being activated at later time points due to diffusion of NO. f) Representative time‐lapse images of Ca2+ responses in TRPV1+ cells in the presence of applied voltages of −1.2 V versus Ag/AgCl and FeCuMoS4 electrocatalysts. Electrodes loaded with FeCuMoS4 electrocatalysts were located at the left in all four images (scale bar: 100 µm). The vertical axis corresponds to GCaMP6s fluorescence intensity, and the color scale was utilized to visualize the GCaMP6s fluorescence changes.
Figure 6
Figure 6
OTOP1 activation mediated by electrosynthesized NH3. a) Schematic of plasmids used to prepare cells co‐expressing OTOP1 and SEpHluorin (left) and the mechanism of NH3‐mediated intracellular alkalinization and consequent activation of OTOP1 (right). b) Schematic illustrating selective intracellular alkalinization by electrochemically produced NH3, but not by NO. Here, cells were positioned near the electrode where NO or NH3 signaling molecules were locally produced. Individual SEpHluorin fluorescence traces for 150 OTOP1+ cells following the electrosynthesis mediated by c) Cu2MoS4 and d) FeCuMoS4 electrocatalysts. −1.2 V versus Ag/AgCl was applied from 30 s (dashed lines) to 900 s. Here, HEK ID refers to individual cells, with each horizontal line representing the SEpHluorin fluorescence changes of the individual cell over time. For each condition, fluorescence responses were recorded from a total of 150 cells (n = 3 independent experiments per group). Time‐lapse images of OTOP1+ cells, which were placed in the vicinity of the electrode, upon applying voltages of −1.2 V versus Ag/AgCl to e) Cu2MoS4 or f) FeCuMoS4 electrocatalysts (scale bar: 100 µm). The vertical axis represents SEpHluorin fluorescence intensity, and the color scale was employed to visualize the SEpHluorin fluorescence changes.

References

    1. Park J., Du P., Jeon J., Jang G. H., Hwang M. P., Han H., Park K., Lee K. H., Lee J., Jeon H., Kim Y., Park J. W., Seok H., Ok M., Angew. Chem. Int. Ed. 2015, 54, 14753–14757; - PubMed
    2. Angew. Chem. 2015, 127, 14966–14970.
    1. Perkons N. R., Stein E. J., Nwaezeapu C., Wildenberg J. C., Saleh K., Itkin‐Ofer R., Ackerman D., Soulen M. C., Hunt S. J., Nadolski G. J., Gade T. P., Commun. Biol. 2018, 1, 48. - PMC - PubMed
    1. Park J., Jin K., Sahasrabudhe A., Chiang P. H., Maalouf J. H., Koehler F., Rosenfeld D., Rao S., Tanaka T., Khudiyev T., Schiffer Z. J., Fink Y., Yizhar O., Manthiram K., Anikeeva P., Nat. Nanotechnol. 2020, 15, 690–697. - PMC - PubMed
    1. Won C., Kim S., Kwak D., Kim T., Kim J., Lee E., Kim S., Adith R. V., Ringe S., Kim H. I., Jin K., Angew. Chem. Int. Ed. 2024, 63, e202411260. - PMC - PubMed
    1. Wang P. G., Xian M., Tang X., Wu X., Wen Z., Cai T., Janczuk A. J., Chem. Rev. 2002, 102, 1091–1134. - PubMed

LinkOut - more resources